TORONTO and SARASOTA, FL -- (MARKET WIRE) -- October 10, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that Ellipsis Biotherapeutics Corporation, its wholly owned subsidiary, has successfully launched several new services in the areas of whole genome association studies and RNA.
